Related Experiment Video
Updated: Feb 22, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Behçet's disease: review with emphasis on dermatological aspects.
Maria Antonieta Rios Scherrer1, Vanessa Barreto Rocha1, Lucas Campos Garcia1
1Contact Dermatitis Outpatient Clinic - Dermatology Division at the Hospital das Clínicas - Universidade Federal de Minas Gerais (UFMG) - Belo Horizonte (MG), Brazil.
Behçet's disease is a systemic vasculitis linked to HLA-B51, involving genetic and environmental factors. Early mucocutaneous symptoms suggest a worse prognosis, highlighting the need for better diagnostic and activity indexes.
Area of Science:
- Immunology
- Genetics
- Rheumatology
Background:
- Behçet's disease is a systemic vasculitis with unknown etiology.
- Strong association with HLA-B51 suggests a genetic component.
- Environmental factors likely play a role in disease development.
Purpose of the Study:
- To review the etiopathogenesis, clinical manifestations, and diagnostic approaches for Behçet's disease.
- To discuss the role of genetic and environmental factors in Behçet's disease.
- To highlight the importance of mucocutaneous manifestations and diagnostic indexes.
Main Methods:
- Literature review of etiopathogenesis, clinical features, and treatment of Behçet's disease.
- Analysis of genetic associations, including HLA-B51 and MICA.
- Review of immunological findings, such as Th1/Th17 responses and cytokine profiles (IL-21).
Main Results:
- Behçet's disease involves genetic susceptibility (HLA-B51) and environmental triggers (e.g., infections).
- Immune system dysregulation includes increased Th1/Th17 responses and IL-21 production.
- Mucocutaneous manifestations (ulcers, skin lesions, pathergy) are key diagnostic markers, with early onset indicating poorer prognosis.
Conclusions:
- Behçet's disease pathogenesis is multifactorial, involving genetic predisposition and immune system activation.
- Early recognition of mucocutaneous signs is crucial for diagnosis and prognosis.
- Further validation of activity indexes like the Mucocutaneous Activity Index is needed for effective management.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Endocarditis II: Clinical Features of Infective Endocarditis
Fungal Phylum Microsporidia

